Perceptive Advisors LLC Madrigal Pharmaceuticals, Inc. Transaction History

Perceptive Advisors LLC

$3.83 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$193.33 - $291.99 $32 Million - $48.3 Million	-165,353 Reduced 38.46%	264,600 $74.1 Million
Q1 2024 May 15, 2024	BUY	$171.37 - $283.23 $47.8 Million - $79 Million	278,802 Added 184.45%	429,953 $115 Million
Q4 2023 Feb 14, 2024	BUY	$120.4 - $237.13 $3.19 Million - $6.29 Million	26,514 Added 21.27%	151,151 $35 Million
Q3 2023 Nov 14, 2023	SELL	$146.04 - $225.78 $26 Million - $40.3 Million	-178,350 Reduced 58.86%	124,637 $18.2 Million
Q2 2023 Aug 14, 2023	SELL	$203.88 - $312.0 $70.9 Million - $108 Million	-347,575 Reduced 53.43%	302,987 $70 Million
Q1 2023 May 15, 2023	SELL	$231.06 - $307.08 $18.8 Million - $25 Million	-81,370 Reduced 11.12%	650,562 $158 Million
Q4 2022 Feb 14, 2023	BUY	$58.39 - $296.54 $23.4 Million - $119 Million	400,909 Added 121.11%	731,932 $212 Million
Q3 2022 Nov 14, 2022	SELL	$60.57 - $79.51 $2.21 Million - $2.9 Million	-36,478 Reduced 9.93%	331,023 $21.5 Million
Q2 2022 Aug 15, 2022	BUY	$58.04 - $100.2 $5.18 Million - $8.94 Million	89,215 Added 32.06%	367,501 $26.3 Million
Q1 2022 May 16, 2022	BUY	$55.89 - $101.89 $10.7 Million - $19.6 Million	191,886 Added 222.09%	278,286 $27.3 Million
Q4 2021 Feb 14, 2022	BUY	$72.34 - $95.09 $6.25 Million - $8.22 Million	86,400 New	86,400 $7.32 Million
Q4 2018 Feb 14, 2019	SELL	$94.77 - $215.54 $209,726 - $476,990	-2,213 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$207.3 - $300.31 $6.22 Million - $9.01 Million	-30,000 Reduced 93.13%	2,213 $474,000
Q2 2018 Aug 14, 2018	SELL	$101.55 - $313.9 $11.2 Million - $34.6 Million	-110,309 Reduced 77.4%	32,213 $9.01 Million
Q1 2018 May 15, 2018	SELL	$93.35 - $149.04 $4.33 Million - $6.91 Million	-46,371 Reduced 24.55%	142,522 $16.6 Million
Q4 2017 Feb 14, 2018	BUY	$39.35 - $97.37 $7.43 Million - $18.4 Million	188,893	188,893 $17.3 Million

Others Institutions Holding MDGL

# of Institutions

298

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

Janus Henderson Group PLC London, X0

2.48M
Shares

$855 Million
0.28% of portfolio
John Paulson Paulson & Co. Inc. | New York, Ny

2.04M
Shares

$705 Million
29.57% of portfolio
Avoro Capital Advisors LLC New York, NY

2.03M
Shares

$700 Million
6.48% of portfolio
Rtw Investments, LP New York, NY

1.99M
Shares

$688 Million
6.74% of portfolio
Baker Bros. Advisors LP New York, NY

1.97M
Shares

$682 Million
4.49% of portfolio

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.9B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Account